Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 28, Issue 3, 2012, Pages 647-654

  Soto, Maria E ^a,b   Secher, Marion ^a,c   Gillette Guyonnet, Sophie ^a,b   Van Kan, Gabor Abellan ^a,b   Andrieu, Sandrine ^a,b,c   Nourhashemi, Fati ^a,b,c   Rolland, Yves ^a,b,c   Vellas, Bruno ^a,b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Alzheimer's disease; cognitive decline; weight loss

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CAREGIVER BURDEN; COGNITIVE DEFECT; COHORT ANALYSIS; COMMUNITY LIVING; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; KATZ ACTIVITY OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MINI NUTRITIONAL ASSESSMENT SCALE; NUTRITIONAL STATUS; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RAPID COGNITIVE DECLINE; RATING SCALE; WEIGHT REDUCTION;

EID: 84858018831     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110713     Document Type: Article

References (38)

1. Clark CM, Sheppard L, Fillenbaum CG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A (1999) Variability in annual Mini Mental State Examination score in patients with probable Alzheimer's disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's disease. Arch Neurol 56, 857-862. (Pubitemid 29318912)
2. Han L, Cole M, Bellavance F, McCusker J, Primeau F (2000) Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: A meta-analysis. Int Psychogeriatr 12, 231-247. (Pubitemid 30490970)
3. Holmes C, Lovestone S (2003) Long-term cognitive and functional decline in late onset Alzheimer's disease: Therapeutic implications. Age Aging 32, 200-204. (Pubitemid 36372428)
4. Doody RS, Massman P, Dunn JK (2001) A method for estimating progression rates in Alzheimer disease. Arch Neurol 58, 449-454. (Pubitemid 32217462)
5. Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA (2003) Rate of cognitive decline and mortality in Alzheimer's disease. Neurology 61, 1356-1361. (Pubitemid 37463370)
6. Soto M, Andrieu S, Cantet C, Reynish E, Ousset PJ, Arbus C, Gillette-Guyonnet S, Nourhashémi F, Vellas B (2008) Predictive value of rapid decline in Mini-Mental State Examination in clinical practice for prognosis in Alzheimer's disease. Dement Geriatr Cogn Disord 26, 109-116.
7. Carcaillon L, Pérés K, Péré JJ, Helmer C, Orgogozo JM, Dartigues JF (2007) Fast cognitive decline at the time of dementia diagnosis: A major prognostic factor for survival in the community. Dement Geriatr Cogn Disord 23, 439-445. (Pubitemid 46897182)
8. Dumont C, Voisin T, Nourhashemi F, Andrieu S, Koning M, Vellas B (2005) Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease. J Nutr Health Aging 9, 163-167. (Pubitemid 40592328)
9. Holtzer R, Wegesin DJ, Albert SM, Marder K, Bell K, Albert M, Brandt J, Stern Y (2003) The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Arch Neurol 60, 1137-1142. (Pubitemid 36975804)
10. Bhargava D, Weiner M, Hynan L, Diaz-Arrastia R, Lipton A (2006) Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol 60, 78-82. (Pubitemid 43726026)
11. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh- Bohmer KA, Breitner JC, Munger R, Lyketsos CG (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850-1858. (Pubitemid 350071146)
12. O'Hara R, Thompson JM, Kraemer HC, Fenn C, Taylor JL, Ross L, Yesavage JA, Bailey AM, Tinklenberg JR (2002) Which Alzheimer patients are at risk for rapid cognitive decline? J Geriatr Psychiatry Neurol 15, 233-238. (Pubitemid 35416170)
13. Boller F, Becker J, Holland A, Forbes MM, Hood PC, McGonigle-Gibson KL (1991) Predictors of decline in Alzheimer's disease. Cortex 27, 9-17.
14. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB (1995) Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci 50, M49-M55.
15. Buccione R, Perri G, Carlesimo A, Fadda L, Serra L, Scalmana S, Caltagirone C (2007) Cognitive and behavioural predictors of progression rates in Alzheimer's disease. Eur J Neurol 14, 440-446. (Pubitemid 46481171)
16. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC (1996) Weight loss precedes dementia in community dwelling older adults. J Am Geriatr Soc 44, 1147-1152. (Pubitemid 26338826)
17. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D, Albarede JL, Vellas (2000) Weight loss in Alzheimer's disease. Am J Clin Nutr 71, 613S-618S.
18. Spaccavento S, Del Prete M, Craca A, Fiore P (2009) Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease. Arch Gerontol Geriatr 48, 356-360.
19. Andrieu S, Reynish W, Nourhashemi F, Ousset PJ, Grandjean H, Grand A, Albarede JL, Vellas B (2001) Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up. J Nutr Health Aging 5, 113-117. (Pubitemid 32539597)
20. White H, Pieper C, Schmader K (1998) The Association of weight change in Alzheimer's disease with severity of disease and mortality: A longitudinal analysis. J Am Geriatr Soc 46, 1223-1227. (Pubitemid 28467424)
21. Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashémi F, Cantet C, Ousset PJ, Grandjean H (2005) Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 9, 75-80. (Pubitemid 40478062)
22. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ, Vellas B (2003) The REAL.FR research program on Alzheimer's disease and its management: Methods and preliminary results. J Nutr Health Aging 2, 91-96. (Pubitemid 36506207)
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. [DSM-IV] APA, Washington [DC], 1997.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
25. Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-Mental- Test: A practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 12, 189-198.
26. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA (1995) Involuntary weight loss in older outpatients: Incidence and clinical significance. J Am Geriatr Soc 43, 329-337.
27. Cummings JL, Mega M, Gray K, Rosenberg-Thompson, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314. (Pubitemid 24382728)
28. Guigoz Y (2006) The Mini Nutritional Assessment (MNA) review of the literature-What does it tell us? J Nutr Health Aging 10, 466-485.
29. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185, 914-919.
30. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1362.
31. Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist 20, 649-655. (Pubitemid 11170845)
32. Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, Cantet C, Ousset PJ, Reynish E, Grandjean H, Vellas B (2006) Outcome of Alzheimer's disease potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci 61, 516-520. (Pubitemid 43794713)
33. Ousset PJ, Nourhashemi F, Reynish E, Vellas B (2008) Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord 22, 66- 71.
34. Rivière S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, Lauque S, Salva A, Frisoni G, Nourhashemi F, Micas M, Vellas B (2001) A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging 5, 295-299. (Pubitemid 33700339)
35. Lauque S, Arnaud-Battandier F, Gillette S, Plaze JM, Andrieu S, Cantet C, Vellas B (2004) Improvement of weight and fat-free mass with oral nutritional supplementation in patients with patients with Alzheimer's disease at risk of malnutrition: A prospective randomized study. J Am Geriatr Soc 52, 1702- 1707.
36. Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK, Wolozin B, Perry G, Zhu X, Greco SJ, Sarkar S (2009) Leptin: A novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis 16, 731-740.
37. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 23, 2565-2572.
38. Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B (2008) Predictive factors of attrition in a cohort of Alzheimer's disease patients. The REAL.FR study. Neuroepidemiology 31, 69-79.